Tokio Marine Asset Management Co. Ltd. increased its position in Heska Corporation (NASDAQ:HSKA) by 76.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,400 shares of the medical research company’s stock after buying an additional 1,900 shares during the period. Tokio Marine Asset Management Co. Ltd. owned about 0.06% of Heska Corporation worth $388,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of HSKA. Victory Capital Management Inc. acquired a new position in shares of Heska Corporation in the first quarter valued at approximately $101,000. Royal Bank of Canada raised its position in shares of Heska Corporation by 96.9% in the second quarter. Royal Bank of Canada now owns 1,014 shares of the medical research company’s stock valued at $103,000 after buying an additional 499 shares during the last quarter. State of Alaska Department of Revenue acquired a new position in shares of Heska Corporation in the second quarter valued at approximately $127,000. LS Investment Advisors LLC raised its position in shares of Heska Corporation by 411.2% in the second quarter. LS Investment Advisors LLC now owns 1,278 shares of the medical research company’s stock valued at $130,000 after buying an additional 1,028 shares during the last quarter. Finally, Municipal Employees Retirement System of Michigan acquired a new position in shares of Heska Corporation in the second quarter valued at approximately $154,000. 80.46% of the stock is owned by institutional investors and hedge funds.
In other Heska Corporation news, CFO John Mcmahon sold 2,608 shares of the business’s stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $101.17, for a total transaction of $263,851.36. Following the completion of the sale, the chief financial officer now directly owns 193 shares in the company, valued at $19,525.81. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Nancy Wisnewski sold 825 shares of the business’s stock in a transaction that occurred on Thursday, August 31st. The stock was sold at an average price of $102.21, for a total transaction of $84,323.25. Following the sale, the executive vice president now owns 38,114 shares of the company’s stock, valued at $3,895,631.94. The disclosure for this sale can be found here. 14.70% of the stock is owned by insiders.
Several brokerages recently commented on HSKA. Aegis upped their price target on shares of Heska Corporation from $114.50 to $129.50 and gave the stock a “buy” rating in a research report on Tuesday, August 1st. B. Riley reaffirmed a “neutral” rating and set a $85.00 price target on shares of Heska Corporation in a research report on Friday, July 28th. Benchmark Co. reaffirmed a “buy” rating and set a $120.00 price target (up previously from $106.00) on shares of Heska Corporation in a research report on Wednesday, August 9th. BidaskClub raised shares of Heska Corporation from a “hold” rating to a “buy” rating in a research report on Thursday, August 3rd. Finally, Zacks Investment Research raised shares of Heska Corporation from a “hold” rating to a “buy” rating and set a $109.00 price target for the company in a research report on Friday, August 4th. Five investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $106.25.
Heska Corporation (HSKA) opened at $86.74 on Friday. The company has a current ratio of 2.30, a quick ratio of 1.12 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $626.79, a P/E ratio of 45.41, a P/E/G ratio of 2.53 and a beta of 0.83.
Heska Corporation (NASDAQ:HSKA) last issued its quarterly earnings results on Thursday, November 2nd. The medical research company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.37 by $0.03. Heska Corporation had a net margin of 10.67% and a return on equity of 15.35%. The firm had revenue of $31.40 million during the quarter, compared to analyst estimates of $36.10 million. During the same quarter in the prior year, the business posted $0.45 earnings per share. Heska Corporation’s revenue for the quarter was down 6.0% compared to the same quarter last year. research analysts predict that Heska Corporation will post 2.04 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This article was reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this article on another website, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this article can be viewed at https://www.com-unik.info/2017/11/05/tokio-marine-asset-management-co-ltd-has-388000-stake-in-heska-corporation-hska.html.
Heska Corporation Profile
Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.
What are top analysts saying about Heska Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Heska Corporation and related companies.